Herbal molecule as potential anti-leukemic drug
OwnerSantu Bandyopadhyay, Bikash Chandra Pal +3inventors
InventorsSantu Bandyopadhyay, Bikash Chandra Pal, Samir Bhattacharya, Keshab Chandra Roy, Gautam Bandyopadhyay
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new use of the compound chlorogenic acid isolated from the piper betel leaf extract or from any other sources for the treatment of acute and chronic myeloid leukemia and lymphoid leukemia, and the present invention also provides a pharmaceutical composition comprising chloregenic acid along with pharmaceutically acceptable additive for the treatment of acute and chronic myeloid leukemia and lymphoid leukemia.
Claims49
A pharmaceutical composition for acute and chronic myeloid leukemia in animals and humans, said composition comprising effective amount of chlorogenic acid (CA) and/or 3-o-p-Coumaryl quinic acid (PCQ), isolated from any plant parts of Piper betel or any other natural or synthetic source and pharmaceutical acceptable additives.
A method of treating acute and chronic myeloid leukemia (AML & CML) and lymphoid leukemia, said method comprising administering a pharmaceutical composition comprising effective amount of chlorogenic acid (CA) and/or 3-o-p-Coumaryl quinic acid (PCQ), isolated from any plant parts of Piper betel or any other source and/or in combination with pharmaceutically acceptable additives.
Dependencies are inferred from the claim text.